Introduction {#S1}
============

The sporogenic Gram-positive bacterium *Bacillus thuringiensis* has gained preeminence among microbial bioinsecticides, including those based on formulations of entomopathogenic fungi, viruses, nematodes, and other bacteria, owing to its insecticidal properties and commercial success worldwide (∼211,000,000 USD; [@B48]). The insecticidal activities of *B. thuringiensis* are generally target-specific and result from proteinaceous protoxins (Cry, crystal; Cyt, cytolytic; δ-endotoxins) that are synthesized at high levels and then crystallized during the sporulation phase of growth ([Figure 1](#F1){ref-type="fig"}). These crystalline inclusions (Cry crystals), also called parasporal bodies, are easily observed with phase contrast microscopy. Cry crystals represent the hallmark of *B. thuringiensis* and its presence distinguishes it from other *Bacillus* species, including *B. cereus*, *B. anthracis*, and *B. subtilis*. When Cry crystals are ingested, they dissolve in the midgut of susceptible larvae. Subsequently, solubilized Cry protoxins are proteolytically activated by enzymes in the digestive juice to generate active entomotoxins that bind to various receptors in the midgut, a precursor to destabilization of osmotic balance and degradation of the midgut epithelia and larval mortality. Indeed, larvae of a number of agronomical pests (e.g., *Plutella xylostella*, *Spodoptera frugiperda*) and arthropod vectors of human diseases (e.g., *Culex*, *Aedes*, and *Anopheles* species) are susceptible to these toxins. Moreover, a wide variety of *cry* genes have been cloned and modified for expression in transgenic plants to resist attack and infestation by insects ([@B71]). Most studies on *B. thuringiensis* have focused on molecular characterization of Cry proteins, mechanisms of toxicity, crystal structure, and identification of new strains that have commercial potential. In contrast, significantly less attention has been paid to other biomolecules of applied interest. Nevertheless, there is growing interest in less-known metabolites synthesized by *B. thuringiensis*, including chitinases (Chi), bacteriocins, vegetative insecticidal proteins (VIP), and siderophores, as they have potential applied value not only in insect control, but also as antibacterial, fungicidal, nematicidal and acaricidal agents, and their ability to directly or indirectly promote plant growth ([@B49]; [@B22]; [@B15], [@B16]; [@B42]; [@B4]). In addition, *B. thuringiensis* also synthesizes proteins called parasporins that lack insecticidal activity, but which are active against human cancer cells ([@B65]). Interestingly, it was recently reported that Cry1Ab and Cry1Ac are also cytotoxic to cervical cancer (HeLa) cells ([@B60]).

![**(I)** Timeline. A brief history of the use of homologous and heterologous chitinases to increase the insecticidal activity of *B. thuringiensis*. **(II)** Different options for the development of recombinant strains of *B. thuringiensis* expressing chitinases. (a) The bacterium can be transformed with heterologous chitinase genes obtained from bacteria other than *B. thuringiensis*. Chitinases harbor signal peptides and are secreted from the cells. (b) The bacterium can be transformed with homologous chitinase genes obtained from different strains of *B. thuringiensis*. Chitinases harbor signal peptides and are secreted from the cells. (c) Chitinase genes from *B. thuringiensis* are engineered and the signal peptide is deleted. Chitinases are expressed inside the cells as inclusion bodies along with the spores and insecticidal Cry proteins. (d) Chitinase genes lacking signal peptides are transcriptionally fused to the C-terminal encoding moiety of *cry1* genes, facilitating the formation of disulfide bridges between the chimeric construct and Cry proteins. This strategy putatively allows the formation of chimeric crystals made of Cry and chitinases. Bt, *B. thuringiensis*; Chi, chitinases; Bt Chi, chitinases from Bt, Cry crystals, parasporal bodies made of Cry proteins; ChiΔsp, chitinase lacking signal peptide; Bt ChiΔsp, chitinase from Bt lacking a signal peptide.](fmicb-10-03032-g001){#F1}

Chitin is a polymer composed of repeating units of *N*-acetyl-*D*-glucosamine and it is found in insects, fungi, shrimp shells, fish scales, mollusks, and also in bird plumage and butterfly wings ([@B62]). It is the second most abundant biopolymer in nature, surpassed only by cellulose. Chitosan is a deacetylated chitin derivate with antibacterial activities. It is commonly used in the manufacture of cosmetics, wood dressings, pool-water treatment agents, and edible films. The use of chitin/chitosan present in seafood shells has also been proposed as a viable alternative to plastics which when used indiscriminately present a major environmental hazard ([@B27]). Chitin occurs as highly ordered, crystalline microfibrils, forming three polymorphs (α, β and γ) composed of ∼100 to 8000 GlcNAc residues depending on the chitin source ([@B46]). The α-type is the most stable form. It possesses strong intermolecular bonding and is found in shells of crustaceans, fungi cell walls, and in insect cuticles. β-chitin has weak intermolecular interactions, and it has been observed in association with proteins in squid pens, cell walls of diatoms, and in the lorica built by seaweeds or protozoa. γ-chitin is considered to be a combination of α- and β-chitin, and it has been detected in *Ptinus* beetle cocoon fibers, the cocoon of *Orgyia dubia*, and the stomach of *Loligo* sp. (squid) ([@B37]; [@B46]).

Biological structures made of chitin are prime targets for chitinolytic enzymes, and as such, phytopathogenic fungi or pest insects are susceptible to degradation by chitinases ([@B61]; [@B45]; [@B38]). Chitinases are produced and secreted by viruses, prokaryotes, and eukaryotes, including humans, plants, fungi, and insects, which interestingly may or not have chitin. Bacteria synthesize a myriad of chitinolytic enzymes to transform chitin to carbon and nitrogen sources which together with other metabolites promote plant growth. Previously, chitinases were classified as endochitinases, exochitinases (chitobiosidases, chitobiases), and N-acetylglucosaminidases, according to the products generated during the hydrolysis process. Currently, and according to the CAZy database^[1](#footnote1){ref-type="fn"}^, chitinolytic enzymes are classified in two general groups: chitinases (EC 3.2.1.14) and β-*N*-acetylhexosaminidases (EC 3.2.1.52), previously called endochitinases and exochitinases, respectively. Chitinases cleave chitin chains at internal sites randomly, whereas β-*N*-acetylhexosaminidases hydrolyze chitin from the non-reducing end of the molecule by removing GlcNAc residues. These enzymes are further grouped into different glycoside hydrolases (GH) families based on their amino acid sequence similarities: endochitinases represent four groups (GH18, GH19, GH23, and GH48), whereas β-*N*-acetylhexosaminidases represent six groups (GH3, GH5, GH18, GH20, GH84, GH116). Most bacterial chitinases belong to the GH18 family.

In particular, interest in the applied value of *B. thuringiensis* chitinases (Bt Chi) was initiated in the 1970s when it was demonstrated that enzymes secreted by this bacterium hydrolyzed chitin ([@B20]). Later, it was shown that *B. thuringiensis* produces chitinases that when used in combination with other components, including Cry proteins, contributed to its virulence ([@B81]; [@B74]; [@B35]). Soon thereafter, cloning of genes coding for *B. thuringiensis* chitinases was reported ([@B86]; [@B7]) which initiated the development of recombinant *B. thuringiensis* strains expressing homologous chitinases. More recently, elucidation of the three-dimensional structure of chitinase ChiA74 ([@B44]) laid a foundation for performing directed evolutionary studies to create a cassette of more stable and efficient enzymes for practical purposes. Several excellent reviews have been published on Cry proteins and a few other metabolites of *B. thuringiensis* ([@B22]; [@B71]; [@B42]; [@B4]), but not on chitinases produced by this bacterium. In this review, our objective is to survey pertinent information published on chitinases of *B. thuringiensis*, with a focus on their phylogeny, regulation, and potential to control insects, microorganisms and nematodes. Recent advances in the structural organization of these enzymes are also discussed, as are our perspective for future studies.

Chitinases of *B. thuringiensis* and Its Modular Organization {#S2}
=============================================================

Chitinases produced by *B. thuringiensis* may play different roles that contribute to the survival of this bacterium under different conditions. For example, these enzymes can be used (i) to sequester and assimilate chitin and use it as a sole source of carbon, and (ii) to act as a virulence factor that promotes the establishment of successful infection by *B. thuringiensis* by compromising structural components, such as the peritrophic membrane through which activated Cry proteins transit in the target host. (iii) Additionally, it is well established that *B. thuringiensis* propagate in moribund and deceased larvae following infection and that several bacterial-based enzymes including proteases, lipases, esterases, and chitinases amplify this process. Chitinases, in particular, can participates in the destruction of the cuticle thereby facilitating the release and dissemination of toxins and spores, and establishment of the bacterium in other ecological niches (e.g., soil, phylloplane) ([@B1]; [@B57]).

Chitinases of *B. thuringiensis* are synthesized at a basal level under the regulation of native promoters, and increased yields require the addition of chitin to the culture medium. To significantly increase chitinase yield for applied commercial purposes, it is essential to identify a myriad of chitinase genes from different niches together with the physical and biochemical parameters that affect the activity of their corresponding enzyme, and also to select the best candidates for hyperexpression in recombinant strains of *B. thuringiensis*. To date, more than 1000 complete genomes and whole-genome shotgun sequences of *B. thuringiensis* have been deposited in the National Center for Biotechnology Information^[2](#footnote2){ref-type="fn"}^. However, ∼50 chitinase genes harbored in different subspecies of this bacterium have been reported in GenBank. Most of the chitinase genes were cloned and sequenced in China (∼41%), followed by Mexico and Pakistan (∼17 and 15%, respectively), and ∼2--4% from Thailand, Brazil, Tunisia, Turkey, Vietnam, Japan, Korea, Egypt, and India ([Table 1](#T1){ref-type="table"}). Based on amino acid sequence alignments, [@B9] classified chitinases of *B. thuringiensis* in four groups. Most of these chitinases showed identities from ∼90 to 99%, but the main difference was observed in the C-terminal end of the deduced amino acid sequences. For example, Group 3 differs from groups 2 and 1 because its members have an addition of ∼12 or 24 amino acids, respectively. Group 1 includes chitinase ChiA74 from *B. thuringiensis* subsp. *kenyae* ([@B7]), whereas four contains only ChiA71, a chitinase from *B. thuringiensis* subsp. *pakistani* ([@B86]). ChiA74 and ChiA71 were the first two chitinases from *B. thuringiensis* genes that were cloned, sequenced and characterized. Interestingly, the main difference between ChiA74 (Group 1) and ChiA71 (Group 4), was the presence of 118 amino acids in the former, but absent in the latter. Also, a 93-amino acid sequence present in the C-terminal region of ChiA71 is absent in ChiA74 ([@B9]). As bacterial chitinases are secreted enzymes they also contain a signal peptide, usually located at the N-terminus, to initiate translocation of the enzyme through the cell wall architecture to the external environment ([@B52]). Interesting, the signal peptide of chitinase of *B. thuringiensis* is also recognized by the secretion machinery of *E. coli*, a Gram-negative bacterium ([@B7]; [@B23]). Most of the chitinases of *B. thuringiensis* have a molecular mass of ∼70 kDa ([@B86]; [@B7], [@B9]; [@B101]; [@B54]; [@B28]; [@B23]; [@B39]), although chitinases of ∼30 kDa have been reported ([@B2]; [@B19]); in general, they have optimal pH activity around 6.5--8.5 with a range temperature of 50--60°C. It is difficult to compare the activity of chitinases from *B. thuringiensis* with other bacterial chitinases, mainly because the differences in the substrates used for the assays and the way to express the units of chitinase activity, i.e., there is no a standardized protocol for determining the activity of bacterial chitinases. Nevertheless, using 4MU-(GlcNAc)~3~ as substrate, it has been observed that ChiA74 from *thuringiensis* has a catalytic efficiency of 1.77 s^--1^μM^--1^ which is higher than ChiA1 from *B. circulans* (0.4 s^--1^μM^--1^), but lower than ChiA and ChiB from *Serratia marcescens* with values of 16 and 8.4 s^--1^μM^--1^, respectively ([@B91]; [@B14]; [@B68]).

###### 

Chitinase genes of *Bacillus thuringiensis* reported in the GenBank.

  **Number**   **Accession numbers**   **Subspecies of *B. thuringiensis***   **Reporting year in the GenBank**   **Origin country**   **References**^∗∗∗^
  ------------ ----------------------- -------------------------------------- ----------------------------------- -------------------- ---------------------
  1            [BTU89796](BTU89796)    *pakistani*                            1997                                Thailand             [@B86]
  2            [AF424979](AF424979)    *kenyae*                               2003                                México               [@B7]
  3            [AF526379](AF526379)    *israelensis*,                         2003                                China                [@B101]
  4            [AY456381](AY456381)    *entomocidus*                          2003                                China                Unpublished
  5            [AY452507](AY452507)    *alesti*                               2003                                China                [@B54]
  6            [AY455290](AY455290)    *canadensis*, strain HD224             2003                                China                Unpublished
  7            [EF211999](EF211999)    Nti^∗∗^, strain BT-7216                2004                                China                Unpublished
  8            [AY452506](AY452506)    *toumanoffi*                           2004                                China                Unpublished
  9            [AY279975](AY279975)    *aizawai*                              2004                                Thailand             Unpublished
  10           [AJ635226](AJ635226)    *kurstaki*                             2005                                Tunisia              [@B28]
  11           [AY074882](AY074882)    Nti                                    2005                                China                Unpublished
  12           [DQ512474](DQ512474)    *colmeri* strain 15A3                  2006                                China                Unpublished
  13           [DQ993175](DQ993175)    *morrisoni*                            2006                                Turkey               Unpublished
  14           [AY129671](AY129671)    *sotto*                                2006                                China                Unpublished
  15           [EF427670](EF427670)    Nti                                    2007                                China                Unpublished
  16           [EU030625](EU030625)    Nti                                    2007                                China                Unpublished
  17           [EF581163](EF581163)    *kurstaki*, strain HD-73               2008                                México               [@B9]
  18           [EU557354](EU557354)    Nti, strain KR 19-22                   2008                                Korea                Unpublished
  19           [EU373094](EU373094)    Nti, strain 97243-1                    2008                                China                Unpublished
  20           [EU373095](EU373095)    Nti, strain H14                        2009                                China                Unpublished
  21           [GQ183830](GQ183830)    *konkukian* strain S4                  2009                                Pakistan             Unpublished
  22           [GQ183831](GQ183831)    *konkukian* strain S4                  2011                                Pakistan             Unpublished
  23           [JX474751](JX474751)    *israelensis*, NRRL HD-522             2012                                Egypt                Unpublished
  24           [HQ418219](HQ418219)    Nti, strain RN52                       2013                                México               [@B76]
  25           [HQ418218](HQ418218)    Nti, strain MR33                       2013                                México               [@B76]
  26           [HQ418217](HQ418217)    Nti, strain MR21                       2013                                México               [@B76]
  27           [HQ418216](HQ418216)    Nti, strain MR11                       2013                                México               [@B76]
  28           [HQ418215](HQ418215)    Nti, strain MR10                       2013                                México               [@B76]
  29           [HE993892](HE993892)    Nti, strain SBS-BT5                    2013                                Pakistan             Unpublished
  30           [KJ010822](KJ010822)    Nti, strain HTS-S-38                   2014                                China                Unpublished
  31           [KJ508093](KJ508093)    Nti, strain DLD171                     2014                                China                Unpublished
  32           [HF542112](HF542112)°   Nti, strain BUPM173                    2014                                Tunisia              Unpublished
  33           [HF542113](HF542113)°   Nti, strain BUPM85                     2014                                Tunisia              Unpublished
  34           [HG792452](HG792452)    Nti, strain SBS-BT6                    2014                                Pakistan             Unpublished
  35           [HG792451](HG792451)    Nti, strain SBS-BT3                    2014                                Pakistan             Unpublished
  36           [HG792449](HG792449)    Nti, strain SBS-BT5                    2014                                Pakistan             Unpublished
  37           [KM249886](KM249886)°   Nti, strain BC-7                       2014                                India                Unpublished
  38           [KF671757](KF671757)    *tenebrionis*, strain 9602             2015                                China                [@B64]
  39           [KJ764712](KJ764712)    *tenebrionis*, DSM2803                 2015                                México               [@B23]
  40           [KJ676691](KJ676691)    Nti, strain I555                       2015                                Brazil               Unpublished
  41           [EF103273](EF103273)    *colmeri* 15A3                         2015                                China                [@B19]
  42           [HE995800](HE995800)    Nti, strain SBS-Bt5                    2015                                Pakistan             Unpublished
  43           [EU734811](EU734811)°   Nti, isolate 66                        2016                                Egypt                Unpublished
  44           [GQ899142](GQ899142)°   *kurstaki*                             2016                                India                Unpublished
  45           [LC194873](LC194873)    *israelensis* ATCC 35646               2017                                Japan                [@B39]
  46           [MF630994](MF630994)    *kurstaki* strain MSS1.1               2017                                Viet Nam             Unpublished
  47           [EF197878](EF197878)    Nti                                    2018                                China                Unpublished
  48           [MK313782](MK313782)    Nti, strain HS66                       2019                                China                Unpublished
  49           [MK032857](MK032857)    Nti, strain HD-73                      2019                                China                Unpublished

°Partial sequences.

∗∗

Nti: Not indicated.

∗∗∗

Information according with the GenBank data (

www.ncbi.nlm.nih.gov

).

Bacterial chitinases have a modular organization where the catalytic domain can be associated with the following modules: chitinase insertion domain (CID), fibronectin type III-like (FnIII), and chitinase binding domain (CBD) ([@B43], [@B44]). The modular organization can vary, as evidenced by *in silico* comparisons with chitinases from other bacteria using the Interpro webserver^[3](#footnote3){ref-type="fn"}^. ChiA74 from *B. thuringiensis* has a similar organization with a chitinase from *B. cereus* but differs from other bacterial chitinases ([Figure 2](#F2){ref-type="fig"}). The variation in the modular organization is in agreement with the diversity in chitin substrate structures ([@B82]). Family 18 chitinases composed of enzymes synthesized by *Bacillus* species are divided into subfamilies A and B. These subfamilies differ by the presence of a chitin insertion domain (CID) found in subfamily A, but absent in B. The catalytic domain is composed of a TIM-barrel that contains an (α/β)8-barrel fold found in many different enzymes. This catalytic domain occasionally has a second domain inserted into the active site of the TIM domain, i.e., CID, which participates in binding and catalytic processes ([@B53]). *B. thuringiensis* chitinases belong to subfamily A and contain the CID domain ([@B44]). The CID is composed of five or six anti-parallel β-strand and one α-helix that alongside the TIM barrel substrate-binding cleft forms a wall that increases the depth of the cleft which suggests the CID facilitates orienting and binding longer saccharide substrates ([@B88]). Most chitinases have one or more chitin-binding domains (CBDs) that are important for interacting with insoluble chitin, and also for facilitating microbial attachment to chitin for subsequent degradation ([@B95]; [@B3]; [@B56]). The CBDs belong to different types of Carbohydrate-Binding Modules (CBMs) and the location of CBDs in chitinases is variable. For example, chitinase ChiA74 from *B. thuringiensis* has one CBD at the C-terminus ([@B43]), the chitinase from *Chitinolyticbacter meiyuanensis* (*Cm*Chi1) has two CBDs between the signal peptide and the catalytic domain ([@B98]), and chitinase Chi92 from *A. hydrophila* (*Ah*Chi92) contains three repeat CBD domains at the C-terminus ([@B95]). There is evidence to suggest that the CBD affects how the enzyme accesses glycosidic bonds within chitin strands ([@B82]). Aromatic amino acids (W, Y) in the CBD are highly conserved and appear to be essential for hydrophobic binding with the pyranosyl rings of N-acetylglucosamine residues in chitin ([@B100]). In particular for ChiA74 the CBD belongs to the carbohydrate-binding type 2 domain subfamily b (CBM2b). This domain has a conserved region of ∼100 amino acids uncommon in chitinases, but present in xylanases ([@B92]). The fibronectin type III-like domain (FnIII) and surface layer homology domains (SLH domain) are present in chitinases of the genera *Bacillus*. In particular, *B. thuringiensis* chitinases possess a FnIII domain composed of a β-sandwich with approximately 100 amino acids. This domain was originally identified in the eukaryotic plasma protein fibronectin and it is part of one of three types of internal repeats (FnI-FnII-FnIII) that arrange other domains in space, acting as a structural spacer ([@B87]). In bacteria, ∼19% of the FnIII domains are found in proteins directly related to carbohydrate metabolism and proteins that contain carbohydrate-binding domains, such as chitinases and cellulases; the location of this domain is between other domains. According to recent reports, in carbohydrate hydrolyzing enzymes the FnIII domain act as a stable linker in multi-domain proteins, as a carbohydrate surface disruption domain, or as a carbohydrate-binding domain. [@B90] suggested that FnIII may help maintain the optimal distance and orientation between catalytic and CBDs in *Bc*ChiA1. Also, in ChiA74 the FnIII might act as a stable linker between the catalytic regions (CDs) and the CBD ([@B44]). On the other hand, it has been suggested that the FnIII domain of a chitinase from *B. thuringiensis* subsp. *tenebrionis* might act synergistically with chitin-binding proteins, helping to attach chitin to the enzyme for efficient substrate hydrolysis ([@B23]).

![Comparison of the modular structure of chitinases of *B. thuringiensis* with different bacterial chitinases and the three-dimensional structure of the ChiA74 from *B. thuringiensis*. **(I)** Modular alignment between different bacterial chitinases. Protein sequences were analyzed using the Interpro webserver ([www.ebi.ac.uk/interpro/beta/](https://www.ebi.ac.uk/interpro/beta/)) and the figure was built with the program DOG 1.0 ([@B75]). The nomenclature used in the CAZy database was maintained. Signal peptide, sp; catalytic domains, GH18; CID, chitinase insertion domain; carbohydrate-binding module, CBM; fibronectin type III domain, FnIII. Chitinase (Chi) of: *Bt*, *B. thuringiensis* (accession number [AF424979.1](AF424979.1)); *Bl*, *B. licheniformis* (QAS14701.1); *Sp*, *Serratia proteamaculans* (AGF70636.1); *Sm*, *S. marcescens* (ABI79318.1); *Sm*, *S. marcescens* AHH32576.1; *Bc*, *B. cereus* (FRI-35 AFQ09088.1); *Cm*, *Chitinolyticbacter meiyuanensis* (ATN39892.1); *Ah*, *Aeromonas hydrophila* (AAG09437.1); *Tk*, *Thermococcus kodakarensis* (BAA88380). **(II)** Crystal structure of the chitinase ChiA74 of *B. thuringiensis* with little additions in the nomenclature to match with **(I)**. The catalytic region (CD) corresponds to the GH18, and chitin binding domain (CBD) to the CBM2 showed in panel **(I)**. This clarification is also shown in **(II)**. The three-dimensional structure was first reported by our group in [@B44], Scientific Reports, available online at <https://doi.org/10.1038/s41598-019-39464-z>.](fmicb-10-03032-g002){#F2}

Finally, the first three-dimensional (3D) structure of the chitinase ChiA74 was elucidated. This crystal structure confirmed the multi-domain assembly of ChiA74 is formed by (i) a CD, (ii) a CID, (iii) a FnIII, and (iv) a chitin binding domain (CBD) ([@B44]). Moreover, this study demonstrated the importance of the catalytic E211 in the CD, as mutants were inactive against a variety of substrates, including colloidal/crystalline chitins, chitosan, and synthetic fluorogenic compounds, and also suggested that the CBD might play a significant role in the hydrolysis of crystalline chitin.

Phylogenetic Analysis and Chitinase Expression {#S3}
==============================================

To determine the genetic relationships of *B. thuringiensis* chitinases, information of the coding sequences reported to date in the GenBank nucleotide sequence database of the National Center for Biotechnology Information^[4](#footnote4){ref-type="fn"}^ were used (see also [Table 1](#T1){ref-type="table"}). Deduced amino acid sequences were aligned with MUSCLE (MUltiple Sequence Comparison by Log- Expectation^[5](#footnote5){ref-type="fn"}^). The chitinase from *B. cytotoxicus* \[NC_009674; [@B10]\] was used as an outgroup and the resulting alignment was exported as a Pearson/FastA file and then submitted to Findmodel software^[6](#footnote6){ref-type="fn"}^ to assess which phylogenetic model optimally described the data. Phylogenetic trees were obtained with MEGA X ([@B47]) and constructed using the Maximum Likelihood method and General Time Reversible + G model. The tree ([Figure 3](#F3){ref-type="fig"}) with the highest log likelihood was obtained with 1000 bootstrap replicates ([@B30]). The phylogram shows an unrooted topology containing some branches with low bootstrap values, supporting a complex evolutionary history for *B. thuringiensis* chitinases. Most sequences with a small number of amino acid replacements were groups in two sister branches with some polytomy with unresolved nodes. A branch sister of *B. cytotoxicus* grouped all *B. thuringiensis* chitinases. The most populated branch separates two sisters, grouping two *B. thuringiensis* subsp. *pakistani* sequences in a branch with 100% bootstrap, and a branch containing six sister groups, one of them showing the largest number of replacements, and the remaining five sisters showing a small number of replacements per site. Sisters with large amino acid replacements branched in two groups, one composed of five chitinases from *B. thuringiensis* subsp. *pakistani*, *colmeri, israelensis*, and *konkukian* and second with a single chitinase from *B. thuringiensis* subsp. *aizawai*.

![Evolutionary analysis of *Bacillus* chitinases by the Maximum Likelihood method. The evolutionary history was inferred by using the Maximum Likelihood method and the General Time Reversible model ([@B63]). The tree with the highest log likelihood (-13605.90) is shown. The percentage of trees in which the associated taxa clustered together is shown next to the branches. Initial tree(s) for the heuristic search were obtained automatically by applying Neighbor-Join and BioNJ algorithms to a matrix of pairwise distances estimated using the Maximum Composite Likelihood (MCL) approach and then selecting the topology with superior log likelihood value. A discrete Gamma distribution was used to model evolutionary rate differences among sites \[5 categories (+*G*, parameter = 1.7979). The tree is drawn to scale, with branch lengths measured in the number of substitutions per site. This analysis involved 44 nucleotide sequences. There was a total of 3234 positions in the final dataset. Evolutionary analyses were conducted in MEGA X ([@B47]). To elaborate this figure, information of the coding sequences of *Bacillus thuringiensis* chitinases reported to date in the GenBank nucleotide sequence database of the National Center for Biotechnology Information (<https://www.ncbi.nlm.nih.gov/>) were taken. Two main groups were distinguished, **(I)** and **(II)**. After each accession numbers are indicated the *B. thuringiensis* (Bt) subspecies and/or the strain types (e.g., Bt *colmeri*, strain 15A3; Bt, strain DLD171) (see in blue) were chitinases were obtained. *B. cytotoxicus* was used as an external group. Additional information on the *B. thuringiensis* strains is shown in [Table 1](#T1){ref-type="table"}.](fmicb-10-03032-g003){#F3}

Regarding target-specific groupings of chitinases, there is scarce information about the effect of chitinases and associated toxicity to "*n*" specific hosts. For example, a chitinase from *B. thuringiensis* subsp. *pakistani* (GenBank accession number [BTU89796](BTU89796)) was used to increase the activity of Cry proteins against *Aedes aegypti* ([@B86]), and ChiA74 from *B. thuringiensis* subsp. *kenyae* (AF424979) against *S. frugiperda*, *M. sexta*, *P. xylostella* (Lepidoptera), and *Aedes aegypti* (Diptera) ([@B17]; [@B6]; [@B45]; [@B34]). Besides these, chitinases from *B. thuringiensis* subsp. *tenebrionis* strain 9602 (KF671757) were active against *Helicoverpa armigera* (Lepidoptera) and *Caenorhabditis elegans* (nematode) ([@B64]), whereas *B. thuringiensis* subsp. *tenebrionis* strain DSM2803 (KJ764712) was active against *Colletotrichum gloeosporioides* (fungus) ([@B23]). Based on these observations, most chitinases shows high sequence similarity, but at the same time, it is difficult to assign chitinase specificity to a discrete host group of insects. Our resulting phylogram suggests that chitinases from *B. thuringiensis* form two main groups (I and II, [Figure 3](#F3){ref-type="fig"}). In the first group, chitinases from *B. thuringiensis* subsp. *tenebrionis* with accession numbers [KF671757](KF671757) and [KJ764712](KJ764712) are effective against *Helicoverpa armigera*, *Caenorhabditis elegans*, and *Colletotrichum gloeosporioides*, respectively ([@B64]; [@B23]), but share the same ancestor. Also, *B. thuringiensis* subsp. *pakistani* (U89796) and *B. thuringiensis* subsp. *kenyae* (AF424979) chitinases that are effective against *A. aegypti*, branch in different groups but share a common ancestor ([@B86]; [@B45]). For the second group, there is no report of the chitinase activity against insects, fungi or nematodes. Because there is scarce evidence about chitinases and their target-specific associations, it is evident that more work is needed to establish the evolutionary histories of *B. thuringiensis* chitinases.

Alternatively, *B. thuringiensis* chitinase gene promoters (e.g., *chiA74* and *chiA71*) harbor −35 and −10 consensus sequences that show identity with *E. coli* promoters and also with promoters recognized by the housekeeping/early sporulation σ^A^ factor of *B. subtilis* ([@B36]; [@B86]; [@B7]; [@B33]). The fact that chitinase gene promoters from *B. thuringiensis* are recognized by the *E. coli* transcriptional machinery provides an important advantage for heterologous expression because it is relatively much easier to work with *E. coli* than with *B. thuringiensis* for different reasons. For example, *E. coli* has a shorter generation time and is a non-sporogenic bacterium. It has been observed that *B. thuringiensis* synthesizes chitinases at basal levels in media lacking chitin, although synthesis can be induced with chitin and repressed with glucose (catabolic repression), factors which may be irrelevant in *E. coli*. Nevertheless, regardless of whether or not glucose is added to a culture of *B. thuringiensis*, basal chitinase synthesis is not suppressed ([@B17]; [@B8]; [@B96]).

The core promoter of the *chiA* gene of *B. thuringiensis* subsp. *israelensis* strain 75 (Bti75) was delimited by fusing the 5′UTR with the β-galactosidase (*bgaB*) gene from *B. stearothermophilus*. When chitin was added to the culture medium, a 2.5-fold increase in the activity of BgaB was observed. Interestingly, a *cis-*active element of ∼16 bp, designed *dre* (DasR responsive elements), is present downstream of the core promoter. The *dre* element plays a role in gene expression as deletion of this sequence resulted in constitutive expression of the chitinase gene ([@B97]). The *dre* sequence has also been reported in other bacteria, including *Streptomyces* and other *Bacillus* species ([@B21]; [@B11]). In *B. thuringiensis*, *dre* acts as a binding site for a negative transcriptional regulator called YVoABt, an N-acetylglucosamine utilization regulator primarily induced by GlcNAc. YVoABt complexes with the phosphoprotein Hpr-ser~45~-P to bind to *dre* ([@B41]) thereby repressing expression of the chitinase gene. However, when the bacterium utilizes chitin as a substrate, GlcNAc or oligosaccharides derived from chitin are produced which leads to the displacement of the repressor and subsequent gene transcription ([@B41]; [@B13]). The YVoABt regulator is also known as NagR~Bt~ because it is an ortholog of NagR in *B. subtilis*. NagRBt is a pleiotropic transcriptional regulator that upregulates and downregulates at least 27 and 14 genes, respectively, in *B. thuringiensis* ([@B13]).

The chitinase gene promoter also contains *cre* (catabolic response element), which is the binding site of a catabolic control protein A (CcpA) that in different Gram-positive bacteria has been identified as the key regulator of the carbon catabolic repression (CCR) process. CcpA can bind specifically to *cre* upon binding to phosphoprotein Hpr-Ser~46~-P ([@B24]). Deletion of the CcpA regulator increases chitinase gene expression and enzyme activity by ∼39-fold ([@B41]). Based on previously reports ([@B24]; [@B97]; [@B41]; [@B13]), we have depicted a model for the regulation mediated by *cre*/CcpA and *dre*/NagR~B~ in [Figure 4](#F4){ref-type="fig"}.

![Schematic representation of the *B. thuringiensis* chitinase regulation. **(I)** The *cre* region is localized into the promoter. This region acts as a site binding of the CcpA, regulator involved in catabolic repression which is helped by the Hpr-Ser~45~-P protein in the presence of glucose. Downstream the promoter is found the *dre* sequence, which acts as operator and binding-site for the negative regulator NagR~Bt~. **(II)** When glucose is absent the CcpA regulator is released from the *cre* sequence, the addition of chitin generates inductors (chitin-oligosaccharides, ChOS) that release the regulator NagR~Bt~ from the *dre* sequence. The presence of both inductors (glucose and chitin) allow chitinase transcription. **(III)** When glucose is presents but chitin is absent, CcpA and NagR~Bt~ are bound to the *cre* and *dre* sequences, respectively, blocking the chitinase transcription. **(IV)** Glucose and chitin present, CcpA binds to *cre* sequence whereas NagR~Bt~ is released from *dre*; however, *chi* is not transcribed because of the inhibition through catabolic repression. **(V)** When glucose and chitin are absent, CcpA is released from *cre* but NagR~Bt~ is bound to *dre*, inhibiting the chitinase transcription. This figure was built taking information published in [@B97], [@B24], [@B41], and [@B13]. Part of a figure published by [@B41] was taken as the basis for the preparation of this figure. Rights and Permissions have been obtained from the American Society for Microbiology and Copyright Clearance Center.](fmicb-10-03032-g004){#F4}

Application of Chitinases {#S4}
=========================

To Improve the Toxic Activity Against Insects, Phytopathogenic Fungi and Nematodes {#S4.SS1}
----------------------------------------------------------------------------------

During the 1970s, and 1990s, it was shown that co-application of spore/crystals and heterologous chitinases or spores/crystals and chitinolytic bacteria increased the insecticidal activity of Cry proteins against the spruce budworm (*Choristoneura fumiferana*) and African cotton leafworm (*Spodoptera littoralis*) larvae, respectively ([@B81]; [@B74]). The enhanced toxicity of the Cry proteins was apparently due to degradation of the chitin-based peritrophic membrane of larvae which allowed increased access of the toxins to their respective receptors on the midgut cells ([@B74]). These observations stimulated the use of heterologous chitinases (i.e., chitinases not synthesized by *B. thuringiensis*), such as those synthesized by *S. marcescens*, *B. circulans*, and *B. licheniformis*, to increase the insecticidal activity of Cry proteins against pest larvae of agricultural importance. For example, ∼0.1 mg/ml chitinase from *S. marcescens* mixed with ∼3 mg per ml of semipurified Cry1C, both produced separately in *E. coli*, caused a maximal reduction in larval weight compared with the use of 20.0 μg of Cry1C per ml without chitinase. Also, the use of a mix of *Pseudomonas fluorescens* transformed with *cry1Ac7* and *chi* of *S. marcescens* showed enhanced toxicity against the sugarcane borer *Eldana saccharina* ([@B26]). As heterologous chitinases mixed with spores/Cry crystals amplified the toxic effect of Cry proteins ([Figure 1](#F1){ref-type="fig"}), the next step was to transform Bt with heterologous genes coding for chitinases. [@B93] made the first attempt to transform *B. thuringiensis* subsp. *israelensis* with chitinase genes from *Aeromonas hydrophila* and *Pseudomonas maltophilia*, but expression was rather low. Later, *B. thuringiensis* subsp. *aizawai* was transformed with chitinase genes from *B. circulans*. The recombinant had a higher level of chitinase activity and improvements in toxicity against gypsy moth larvae (*Lymantria dispar*) were observed ([@B50]; [@B51]). An interesting observation was that combining 10 mU of *B. licheniformis* chitinases with spores/Cry crystals of *B. thuringiensis* subsp. *aizawai* against *S. exigua* resulted in a decrease in LD~50~ by approximately 15-fold at 7 days, compared to the use of spores/crystals alone. However, when *B. thuringiensis* subsp. *aizawai* was transformed with a chitinase gene from *B. licheniformis*, a low level of chitinase synthesis was observed with no change in the toxic effect when compared with the parental strain ([@B84]). Additionally, a chitinase gene from *B. licheniformis* TP-1 was used to transform *B. thuringiensis* subsp. *israelensis*; the transformant produced a lower number of spores and was less toxic to *A. aegypti* larvae when compared with the parental strain ([@B80]). These observations indicated that the synthesis of heterologous chitinases in *B. thuringiensis* requires optimization of expression systems and/or maintaining the efficacy of the enzyme, which unlike Cry proteins is not crystallized to form a stable inclusion prior to delivery to the larval target. In other regards, whereas most studies focused on the use of chitinases combined with spore/crystal mixtures against lepidopterans and dipterans, specifically mosquito larvae, the potential for such a strategy to control coleopterans was also demonstrated. [@B66] showed that an anti-coleopteran recombinant *B. thuringiensis* strain 3023 expressing the *chiA* gene of *S. marcescens* was 5.2- and 1.3-fold more toxic than, respectively, parental 3023 strain and *S. marcescens*.

Because the expression of heterologous chitinases using plasmids can be unstable after a certain number of generations, particularly in the absence of antibiotic selection in the larvae host, the integration of chitinase gene into the bacterial chromosome presented a viable alternative. [@B85] integrated a chitinase gene from *B. licheniformis* under control of the P19 promoter into the chromosome of *B. thuringiensis* subsp. *aizawai* (BTA1) and observed that the growth and sporulation profiles were comparable to the wild-type strain. Preparations of whole culture broth of the recombinant against *S. exigua*, compared with the wild strain, showed a 2.5× reduction in the LC~50~, i.e., from 30.8 microgram/cm^2^ to 12.2 microgram/cm^2^. Years later, the same group transformed BTA1 with the chitinase gene of *B. licheniformis* but under the control of the *cry11Aa* sporulation-dependent promoter. The activity of the recombinant strain against *S. litura* was enhanced by ∼4.6-fold compared to the wild-type strains, a result due to the increase in chitinase synthesis and enzymatic activity which synergized the effect of Cry1A ([@B12]). Besides, endogenous chitinases of *B. thuringiensis* subsp. *israelensis* IPS78 and *B. thuringiensis* subsp. *aizawai* HD133 have also been implicated in the pathogenicity against, respectively, *Culicoides nubeculosus* and *S. littoralis*. This was demonstrated because the use of allosamidin (a chitinase inhibitor) in the bioassays increase the LD~50~ (i.e., less toxic) compared to a control lacking the inhibitor ([@B78]), indicating that chitinase inhibition abolishes the contribution of these enzymes to the toxic effects of Cry proteins. It has been shown that wild-type strains of *B. thuringiensis* produce a basal level of chitinase in culture medium, and that synthesis of the enzyme can be induced or repressed with chitin or glucose, respectively ([@B8]; [@B96]). The levels of chitinase synthesis can be determined by *in vitro* assays, qualitatively by the observation of halo formations in solid medium supplemented with colloidal chitin, or quantitatively by measuring reducing sugars and by fluorescence emission using synthetic fluorogenic chitin-derivates when the bacterium is grown in a liquid medium ([@B5]; [@B55]; [@B32]). As endogenous chitinases of *B. thuringiensis* are involved in virulence against insects ([@B78]), secreted chitinases present in a culture medium might be useful to increase the insecticidal activity of *B. thuringiensis*. This was verified when secreted chitinases of *B. thuringiensis* in the culture supernatants when mixed with spores/Cry crystals increased toxicity against *P. xylostella*, *S. exigua*, and *Choristoneura fumiferana* ([@B94]; [@B55]; [@B89]).

On the other hand, previous studies revealed that *B. thuringiensis* is antagonistic to phytopathogenic fungi due to the production of lytic enzymes, including chitinases. Therefore, chitinases are also considered as promising biocontrol agents to protect plants, particularly those of high economic value, from infestation and damage by phytopathogenic fungi. The mode of action of *B. thuringiensis* against fungi differs depending on the strains. For example, different morphological effects on fungal cell walls have been noted, such as inhibition of mycelial growth and spore germination, lysis of spores and hyphal tips, and germ tube elongation ([@B69]). Specifically, the inhibition of phytopathogenic fungi using bacterial suspensions, supernatants, concentrated crude preparations containing chitinases, and purified chitinases of *B. thuringiensis* have been described. It has also been reported that there is no significant difference in antifungal activities of *B. thuringiensis* between the crude extract and purified chitinase ([@B61]), although [@B59] showed that purified chitinase was unable to inhibit the growth of *Fusarium oxysporum* and *Helminthosporium sativum* when compared to the activity observed with crude extracts. Isolates of *B. thuringiensis* have shown antifungal potential in dual cultivation assays. For example, [@B38] showed *in vitro* antagonism toward *Verticillium dahlia*, a pathogen with a broad host range, including economically important crops such as tomato. The authors suggested that the inhibitory effect on the growth of the phytopathogens was attributed to the presence of chitinases in the supernatant of the bacterial culture. Similar results were obtained with supernatant preparations against *Aspergillus niger*, *A. foetidus*, and *A. ochraceus* ([@B28]; [@B69]) in which the antifungal effect was attributed not only to the presence of chitinases but also to a complex of hydrolytic enzymes, including proteases and gluconases. Regardless, inhibitory effects against fungi have been demonstrated using partially purified or purified chitinases of *B. thuringiensis*, and these species-specific enzymes were more effective than those produced by *B. licheniformis* against species of *Fusarium*, *Rhizopus*, and *Trichoderma* ([@B61]; [@B31]; [@B58]). More recently, a purified chitinase from *B. thuringiensis* subsp. *tenebrionis* DSM-2803 was shown to adversely affect the growth of *Colletotrichum gloeosporioides*, a potent phytopathogen that causes "anthracnose" in avocado (*Persea americana*), and one that is responsible for significant economic loss in México ([@B23]). Other studies have also shown the adverse effect of *B. thuringiensis* chitinases against *F. oxysporum*, the etiological agent of the fungal vascular wilt of date palm, an important traditional crop in North Africa and The Middle East ([@B64]; [@B25]). Phytopathogenic fungi alter plant physiology and cause disease throughout development, including during seed germination. Therefore, the effect of chitinase on germination of seeds infested with phytopathogenic fungi has also been evaluated. [@B31] showed that crude extracts from *B. thuringiensis* increased the rate of germination of soybean seeds infested with phytopathogens (e.g., *Aspergillus terreus*) by 7.6-fold when compared to controls. Similar positive effects were observed by [@B61] with the treatment of seeds infested with *Pestalotia* sp. and *A. niger*. Furthermore, [@B79] reported that chitinase produced by *B. thuringiensis* GS1 inhibits the growth of *Rhizoctonia solani* in cucumber plants. Finally, it is also interesting to note that chitinases can induce plant defenses against these microbial pathogens. For example, when rice seedlings were treated with immobilized purified chitinase from *B. thuringiensis* H3, an increase in the synthesis of defense enzymes, including peroxidase and phenylalanine ammonia-lyase, was observed ([@B83]).

While several studies have demonstrated the potential use of *B. thuringiensis* chitinase to control insects and fungi, only a few have been reported on the effect of these enzymes on free-living nematodes such as *Caenorhabditis elegans.* Studies by [@B99] suggested that the detrimental activity of *B. thuringiensis* strain 010 against *C. elegans* could be due to the action of chitinases. More recently, a mutant (ChiW50A) of chitinase Chi9602 of *B. thuringiensis* subsp. *tenebrionis* YBT-9602 with ∼60% higher enzymatic activity elicited an increase of ∼20% in mortality against *C. elegans* when compared with the parental strain ([@B64]). Moreover, nanoparticles made of immobilized *B. thuringiensis* chitinases (i.e., Chi9602) showed enhanced nematicidal effects against *C. elegans* ([@B73]).

To Generate Antibacterial Chitin-Derived Oligosaccharides {#S4.SS2}
---------------------------------------------------------

Chitinases of *B. thuringiensis* subsp. *pakistani* (ChiA71), *B. thuringiensis* (Chi255) and *B. thuringiensis* subsp. *aizawai* have been shown to hydrolyze colloidal chitin to primarily produce GlcNAc and (GlcNAc)~2~ suggesting that these enzymes possess an exo-type chitinase activity ([@B86]; [@B28]; [@B61]). In particular, thin layer chromatography (TLC) demonstrated that ChiA74 of *B. thuringiensis* subsp. *kenyae* when produced in *E. coli* can generate chitin-derived oligosaccharides (ChOGs) with degrees of polymerization higher than 2, suggesting an endochitinase activity. However, more recently it was shown that purified ChiA74 has a processive activity generating mainly GlcNAc and (GlcNAc)~2~ when using colloidal chitin as substrate, suggesting that purified ChiA74 has an exochitinase action and the previous endochitinase activity could be erroneous because the ChiA74 preparation could have been mixed with other enzymes in crude extracts ([@B14]; [@B44]). Nevertheless, the resulting ChOGs exhibited antimicrobial activities against a number of clinically significant Gram-positive and Gram-negative bacteria, including *B. cereus*, *Listeria monocytogenes*, *Staphylococcus aureus*, *Staphylococcus xylosus*, *Klebsiella pneumoniae*, *Pseudomonas aeruginosa*, *Shigella sonnei*, *Shigella flexneri*, and *Proteus vulgaris* ([@B9]; [@B67]; [@B18]).

Development of Recombinant *B. thuringiensis* Strains Expressing Homologous Chitinase Genes {#S5}
===========================================================================================

Chitinase genes from *B. thuringiensis* have been used as a resource to generate recombinant strains of the same species. These recombinants can be classified into three categories: (i) strains expressing chitinases that can be secreted and collected from supernatants, (ii) recombinants that synthesize chitinases lacking the secretion signal thereby leading to amorphous intracellular inclusions of the enzyme that are released together with the spores/crystals following autolysis, and (iii) strains producing inclusions composed of the chitinase fused in frame with the C-terminal (crystallization) domain of Cry proteins ([Figure 1](#F1){ref-type="fig"}). Currently, there is no report about the development of *B. thuringiensis* strains with homologous chitinase genes inserted into the chromosome.

Regarding the first category, *B. thuringiensis* HD73 was transformed with chitinase *chiA74* under the control of the wild-type promoter (HD-73-pEHchiA74) or the *pcytA-STAB* system (HD-73-pEBchiA74) ([@B17]; [@B8]). The *pcytA* sequence is composed of three strong sporulation-dependent promoters \[BtI(σ^E^), BtII(σ^K^), BtIII(σ^E^)\] which contribute to the high expression level, and the STAB sequence contributes to the stabilization of the mRNA ([@B72]; [@B77]). HD-73-pEBchiA74 showed an increase in enzymatic activity of 58- and 362-fold higher than HD-73-pEHchiA74 and parental HD-73, respectively, but with a compensating reduction in Cry crystal size and number of viable spores when compared to the wild-type HD73. This, unfortunately, did not increase in toxicity against *P. xylostella* when compared to the parental strain ([@B17]).

Concerning the second category, the deletion of the secretion signal peptide led to intracellular accumulation and formation of inclusion bodies composed of the enzyme ([@B6]). The premise for developing *B. thuringiensis* strains that synthesize chitinase as intracellular inclusions is based on the fact the upon autolysis crystals, spores and chitinase inclusion bodies are released simultaneously. For example, a chitinase from *B. thuringiensis* strain 4.0718 under the control of dual overlapping promoters plus Shine-Dalgarno sequence and terminator sequence of *cry1Ac3* was introduced into Cry^--^B, an acrystalliferous *B. thuringiensis* strain that does not produce Cry crystals. Chitinase inclusion bodies were formed and exhibited chitinase activity. When these inclusion bodies were mixed with Cry crystals, an increase in the toxicity of Cry1Ac against larvae of *S. exigua* and *Helicoverpa armigera* was observed ([@B40]). As the authors transformed an acrystalliferous strain, they could not study the effect on the production of the insecticidal crystal proteins. To produce chitinase inclusion bodies and Cry crystals in the same *B. thuringiensis* host, *chiA74*Δsp lacking the signal peptide sequence under the control of the *pchiA* wild-type promoter (pEHchiA74Δsp) or the *pctyA*-STAB system (pEBchiA74Δsp) was introduced into *B. thuringiensis kurstaki* HD1 and *B. thuringiensis* subsp. *israelensis* IPS-82, strains that are commonly used in formulations of commercial products. In HD1 ChiA74Δsp inclusions were dissolved in alkali and reducing conditions, similar to Cry crystals, and the enzyme retained its activity in a wide range of pH (5--9) but showed a drastic reduction (∼70%) at pH 10. Compared to parental HD1 strain, the recombinant HD1-pEBchiA74Δsp showed a 42-fold increase in chitinase activity and a 3-fold increase in the number of viable spores, but the bipyramidal Cry crystals were ∼30% smaller. Bioassays against first instar larvae of *M. sexta* with spore-crystals of HD1 or spore-crystal-ChiA74Δsp inclusions of HD1-pEBchiA74Δsp showed LC~50~ of 67.30 and 41.45 ng/cm^2^, respectively ([@B6]). When *B. thuringiensis* subsp. *israelensis* was transformed with *chiA74Δsp*, the recombinants produced their native Cry crystals composed of Cry4Aa, Cry4Ba, Cry11Aa, and Cyt1Aa and also ChiA74Δsp inclusions. These recombinants showed ∼3-fold increase in both chitinase activity and viable spore count when compared with the parental strain and were twofold more toxic than *B. thuringiensis* subsp. *israelensis* against fourth instars of *A. aegypti* larvae ([@B45]).

Finally, chimeric fusions of chitinase with the C-terminal domains of Cry proteins have been reported in two studies. In the first study, the sequence coding a chitinase of *B. thuringiensis* subsp. *kurstaki* BUPM255 under the regulation of pBtI-BtII was transcriptionally fused to the C-terminal domain of *cry1Ac* and the construct was used to transform *B. thuringiensis* BNS33. The recombinant showed a 2.5-fold increase in chitinase activity and was 1.5× more toxic to *Ephestia kuehniella* when compared to the parental strain ([@B29]). Unfortunately, the authors did not report whether the chimeric protein formed inclusions or retained enzymatic activity in lyophilized preparations. A similar study was performed by [@B34], where the *chiA74* gene lacking its secretion signal peptide sequence (*chiA74Δsp*) was fused in frame with the sequence coding for the C-terminal crystallization domain and transcription terminator of *cry1Ac*, under the regulation of s*pcytA-p/*STAB-SD promoter system, and the construct was used to transform *B. thuringiensis* subsp. *kurstaki* HD73. Amorphous inclusions apparently composed of the chimera and native bipyramidal Cry1Ac crystals were observed. The chitinase activity of purified Cry1Ac/amorphous inclusions was 51-fold higher when compared to purified Cry1Ac inclusions of parental HD73. Bioassays against larvae of *S. frugiperda* with spore/crystals of HD73 or spore-crystals-ChiA74Δsp chimeric inclusions of recombinant HD73 showed a reduction of 30% in the LC~50's~ when compared to wild-type HD73, indicating that the enhancement in toxicity directly correlated to the presence of the atypical amorphous component.

Future Perspective {#S6}
==================

*Bacillus thuringiensis* is a fascinating microbe for several reasons, but primarily for its ability to produce a plethora of molecules that have applied or potential applied value. Unequivocally, this microbe should be viewed as a microbial factory that can be engineered and exploited for simultaneous production of Cry and Cyt proteins, VIPs, parasporins, chitinases, and other metabolites that target vectors of human diseases, cancers, clinically significant microbial pathogens, and agricultural pest.

In spite of recent advances in the study of the *B. thuringiensis* chitinases, several issues need to be resolved. In particular, with regard to its entomocidal potential, it has been demonstrated that chitinases from *B. thuringiensis* increase the toxic effect of Cry proteins, but there is no evidence to show whether these enzymes act synergistically or merely potentiate the activity of Cry. There appears to be little or no evidence to support a hypothesis that substantial increases in chitinase production and enzymatic activity translate to substantial decreases in LC~50's~. In this regard, definitive studies are required to determine the fate of chitinases in the insect midgut after ingestion. Are these enzymes relatively stable or are they rapidly degraded by digestive proteases? Indeed, it is not clear whether the chitinolytic activity of a particular chitinase is insect-species specific, or whether optimal catalysis for the enzyme is dependent on the organization and variation of chitin in the peritrophic membrane. Our phylogenetic analysis suggests that chitinases from *B. thuringiensis* can be grouped in different clusters, but whether members in these clusters have species-specific targets requires an extensive study that realistically will not be completed in the near future. Assuming that chitinases are stable and active in the physical and biochemical environment of the midgut, at least for the time required for activation of Cry toxins, the questions of whether inclusions of the enzyme produced in microbial factories (including *B. thuringiensis*) dissolve efficiently *in vivo*, and if the solubilized forms of the enzyme refold properly for effective catalysis are interesting and worth addressing. The extent of antifungal and nematicidal effects of chitinases produced by *B. thuringiensis* remains questionable in our view. More focused studies on a variety of these enzymes assayed on individual fungal and nematode species could provide valuable insights into selecting the best, or suitable, candidates for further research and development. Moreover, basic molecular research is required to elucidate the translocation mechanism(s) of chitinases in *B. thuringiensis*, although it is likely that a system analogous to that in *E. coli* is involved, based on the observation that chitinases of *B. thuringiensis* origin are secreted by this Gram-negative bacterium. Moreover, whether the chitinases of *B. thuringiensis* have a processive or non-processive mechanism of chitin hydrolysis needs to be determined.

Finally, due to the structural differences and characteristics that chitinases have, their use in specific practical applications can be difficult to determine and optimize ([@B68]). However, we believe that many of these issues will ultimately be resolved and that the recent structural analyses ([@B70]; [@B44]) will be indispensable toward this end. With this knowledge, and with the use of genome editing technologies and new synthetic biology and computational tools, the performance of chitinases could be improved. For instance, due to the modularity of chitinases, the creation of new synthetic chitinases derived from a combination of different protein domains could enable the creation of new tailor-made chitinases with new functions. These new synthetic chitinases could then be used for specific biotechnological applications and potentially help increase the market demand for chitinolytic enzymes derived from microbial cell factories like *B. thuringiensis*.
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